These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21874231)

  • 1. Decreased accumulation of immune regulatory cells is correlated to the antitumor effect of IFN-γ overexpression in the tumor.
    Carrio R; Torroella-Kouri M; Libreros S; García-Areas RA; Iragavarapu-Charyulu V; López DM
    Int J Oncol; 2011 Dec; 39(6):1619-27. PubMed ID: 21874231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of myeloid-derived suppressor cells and T regulatory cells in lung microenvironment after Urethane-induced lung tumor.
    Rosin FC; Pedregosa JF; de Almeida JS; Bueno V
    Int Immunopharmacol; 2011 Jul; 11(7):873-8. PubMed ID: 21238620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+, but not CD8+, T cells from mammary tumor-bearing mice have a down-regulated production of IFN-gamma: role of phosphatidyl serine.
    Cheng X; Lopez DM
    J Immunol; 1998 Mar; 160(6):2735-41. PubMed ID: 9510174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
    duPre' SA; Redelman D; Hunter KW
    Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice.
    Handel-Fernandez ME; Cheng X; Herbert LM; Lopez DM
    J Immunol; 1997 Jan; 158(1):280-6. PubMed ID: 8977200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase.
    De Ridder M; Verovski VN; Chiavaroli C; Van den Berge DL; Monsaert C; Law K; Storme GA
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1473-80. PubMed ID: 17056198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of stromal fibroblasts to IFN-gamma blocks tumor growth via angiostasis.
    Lu Y; Yang W; Qin C; Zhang L; Deng J; Liu S; Qin Z
    J Immunol; 2009 Nov; 183(10):6413-21. PubMed ID: 19841170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
    Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
    Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
    Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming.
    Romieu-Mourez R; François M; Abate A; Boivin MN; Birman E; Bailey D; Bramson JL; Forner K; Young YK; Medin JA; Galipeau J
    Cancer Res; 2010 Oct; 70(20):7742-7. PubMed ID: 20924101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory role of Vγ1 γδ T cells in tumor immunity through IL-4 production.
    Hao J; Dong S; Xia S; He W; Jia H; Zhang S; Wei J; O'Brien RL; Born WK; Wu Z; Wang P; Han J; Hong Z; Zhao L; Yin Z
    J Immunol; 2011 Nov; 187(10):4979-86. PubMed ID: 21987661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
    Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma.
    Choi BK; Kim YH; Kim CH; Kim MS; Kim KH; Oh HS; Lee MJ; Lee DK; Vinay DS; Kwon BS
    J Immunol; 2010 Aug; 185(3):1404-11. PubMed ID: 20610645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
    Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
    J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
    Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
    Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    Clin Immunol; 2001 Jan; 98(1):70-84. PubMed ID: 11141329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1.
    Carrio R; Lopez DM
    Int J Mol Med; 2009 Jan; 23(1):89-98. PubMed ID: 19082511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.